These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1250 related items for PubMed ID: 25701530

  • 21. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
    Auer TA, Walter-Rittel T, Geisel D, Schöning W, Schmelzle M, Müller T, Sinn B, Denecke T, Hamm B, Fehrenbach U.
    BMC Med Imaging; 2021 Feb 15; 21(1):28. PubMed ID: 33588783
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
    Janica J, Serwatka W, Polaków J, Ustymowicz A, Walecki J, Ladny JR, Dobrzycki S.
    Med Sci Monit; 2004 Jun 15; 10 Suppl 3():17-21. PubMed ID: 16538193
    [Abstract] [Full Text] [Related]

  • 23. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.
    J Magn Reson Imaging; 2015 Nov 15; 42(5):1249-58. PubMed ID: 25851028
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C, Soler JC, Ayuso JR, Caseiro-Alves F, Ayuso C.
    Radiol Med; 2021 Nov 15; 126(11):1379-1387. PubMed ID: 34287759
    [Abstract] [Full Text] [Related]

  • 25. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
    Bartolotta TV, Sandonato L, Taibbi A, Latteri S, Soresi M, Lombardo G, Genova C, Latteri MA.
    Chir Ital; 2009 Nov 15; 61(3):295-307. PubMed ID: 19694231
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver.
    Piscaglia F, Venturi A, Mancini M, Giangregorio F, Vidili G, Magnolfi F, Mirarchi M, Fornari F, Bolondi L.
    Ultraschall Med; 2010 Jun 15; 31(3):276-82. PubMed ID: 19941252
    [Abstract] [Full Text] [Related]

  • 27. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography.
    Ungermann L, Eliás P, Zizka J, Ryska P, Klzo L.
    Eur J Radiol; 2007 Aug 15; 63(2):290-4. PubMed ID: 17353110
    [Abstract] [Full Text] [Related]

  • 28. Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography.
    Bartolozzi C, Lencioni R, Paolicchi A, Moretti M, Armillotta N, Pinto F.
    Eur Radiol; 1997 Aug 15; 7(9):1410-5. PubMed ID: 9369506
    [Abstract] [Full Text] [Related]

  • 29. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S.
    Radiology; 2012 Feb 15; 262(2):520-9. PubMed ID: 22282184
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS.
    AJR Am J Roentgenol; 2012 Jul 15; 199(1):26-34. PubMed ID: 22733890
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.
    Pei XQ, Liu LZ, Xiong YH, Zou RH, Chen MS, Li AH, Cai MY.
    Br J Radiol; 2013 Mar 15; 86(1023):20120536. PubMed ID: 23392189
    [Abstract] [Full Text] [Related]

  • 39. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, Gabata T.
    AJR Am J Roentgenol; 2018 Aug 15; 211(2):347-357. PubMed ID: 29708786
    [Abstract] [Full Text] [Related]

  • 40. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.
    Lee J, Jeong WK, Lim HK, Kim AY.
    J Ultrasound Med; 2018 Jun 15; 37(6):1473-1480. PubMed ID: 29159819
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 63.